Colorectal Polyp Prevention Support Protocol
Primary Stack
Core supplements with strongest evidenceBinds bile acids and fatty acids in colon; reduces cell proliferation; studied for polyp recurrence prevention
May enhance calcium's protective effects; anti-proliferative effects on colon cells; deficiency linked to increased risk
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsIncreases stool bulk; reduces transit time; dilutes carcinogens; produces beneficial short-chain fatty acids
Supporting Studies (1)
Anti-inflammatory; may reduce COX-2 and prostaglandins in colon; studied for polyp prevention
Supporting Studies (1)
Supports DNA synthesis and repair; deficiency may increase colorectal cancer risk; complex relationship
Supporting Studies (1)
Supports healthy gut microbiome; may produce protective short-chain fatty acids; emerging area
Supporting Studies (1)
Anti-inflammatory; laboratory studies show effects on colorectal cancer cells; limited human trial data
Supporting Studies (1)
Polyphenols with anti-cancer properties; studied for colorectal adenoma prevention
Supporting Studies (1)
Antioxidant; some observational data suggest lower colorectal cancer risk with adequate selenium
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Colorectal polyps are growths on the inner lining of the colon or rectum. While most polyps are benign, some types (adenomatous polyps or adenomas) can develop into colorectal cancer over time. Removing polyps during colonoscopy prevents cancer.
TYPES OF POLYPS:
SCREENING SAVES LIVES:
LIFESTYLE FACTORS that reduce polyp risk:
MEDICATIONS sometimes used:
* Calcium with Vitamin D has the strongest evidence for reducing adenoma recurrence.
* Fiber supports healthy colon function and may reduce risk.
* Omega-3 Fatty Acids have anti-inflammatory effects that may help prevent polyps.
Expected timeline: Prevention is a long-term commitment. Studies showing benefit typically follow patients for 3-5 years. Regular colonoscopy surveillance is essential regardless of supplement use.
Clinical Perspective
Colorectal Polyps: Adenomatous polyps (adenomas) are precursors to colorectal cancer; adenoma-carcinoma sequence takes 10-15 years. Types: tubular, tubulovillous, villous (highest malignant potential). Risk factors: age, family history, IBD, Lynch syndrome, FAP. Surveillance: based on polyp number, size, histology, family history; intervals 3-10 years. Screening: colonoscopy recommended starting age 45 (USPSTF 2021).
CRITICAL: Colonoscopy with polypectomy is definitive prevention. Surveillance intervals must be followed. Lifestyle modification (diet, weight, exercise, no smoking) has strongest evidence. Supplements may provide additional benefit but do not replace screening. Low-dose aspirin may be recommended for some - discuss with physician.
* Calcium (B-grade): Bile acid binding; cell proliferation. Systematic review: (PMID: 26443622). Meta-analysis: (PMID: 29049439). 1000-1200mg daily.
* Vitamin D (B-grade): Synergy with calcium; anti-proliferative. Meta-analysis: (PMID: 28750270). 2000-4000 IU daily. Target 40-60 ng/mL.
* Fiber (B-grade): Stool bulk; short-chain fatty acids. Meta-analysis: (PMID: 25623152). 25-35g daily.
* Omega-3 Fatty Acids (B-grade): Anti-inflammatory. Systematic review: (PMID: 27840029). 2-4g EPA+DHA daily.
* Folate (C-grade): DNA repair; complex relationship. Systematic review: (PMID: 27450775). 400-800mcg daily. Food sources preferred.
* Probiotics (C-grade): Microbiome; SCFA. Review: (PMID: 29882905). Multi-strain daily.
* Curcumin (C-grade): Anti-inflammatory. Review: (PMID: 25282711). 500-2000mg daily.
* Green Tea (C-grade): Polyphenols. Trial: (PMID: 26440377). 300-400mg EGCG daily.
* Selenium (C-grade): Antioxidant. Meta-analysis: (PMID: 28558777). 100-200mcg daily.
Assessment targets: Colonoscopy findings, adenoma recurrence, dietary habits, weight, vitamin D levels.
Protocol notes: Surveillance intervals: 1-2 adenomas <10mm = 7-10 years; 3-4 adenomas <10mm or any adenoma >=10mm = 3 years; 5-10 adenomas = 3 years; >10 adenomas = 1 year. High-risk: Lynch syndrome (1-2 year colonoscopy), FAP (colectomy usually needed). Aspirin: USPSTF recommends for cardiovascular prevention; may also reduce CRC risk; bleeding risk must be weighed. Red meat: limit to <3 servings/week; processed meat associated with increased risk. Alcohol: limit to 1 drink/day women, 2/day men. Obesity: increases risk; weight loss beneficial. Exercise: 30+ min moderate activity most days. Smoking: cessation reduces risk. Folate: adequate intake protective; high-dose supplements may be harmful if existing adenoma/cancer. Calcium: food sources preferred; supplements may increase cardiovascular risk in some. Family history: first-degree relative with CRC = earlier and more frequent screening. IBD: increased risk; surveillance colonoscopy with biopsies.